Stoke Therapeutics, Inc. — Institutional Ownership
Which tracked institutions hold STOK, and how they changed the position last quarter. Latest holdings as of Jun 30, 2026. Source: SEC 13-F filings.
24
Funds holding
$634240248
Total value held
Buying
17 added/new · 5 reduced
| # | Institution | Value | Shares | Δ Shares | Change (QoQ) |
|---|---|---|---|---|---|
| 1 | Blackrock, Inc. | $192307120 | 5877357 | +491643 | +9.13% |
| 2 | Morgan Stanley | $112975453 | 3452795 | +29515 | +0.86% |
| 3 | Toronto Dominion Bank | $103829002 | 3173258 | — | Held |
| 4 | State Street Corp | $93325293 | 2852240 | +575728 | +25.29% |
| 5 | Janus Henderson Group Plc | $52455703 | 1612781 | +1612781 | NEW BUY |
| 6 | Goldman Sachs Group Inc | $18825256 | 575344 | -255358 | -30.74% |
| 7 | Northern Trust Corp | $16364057 | 500124 | +68494 | +15.87% |
| 8 | Bank Of America Corp /De/ | $8497646 | 259708 | -283387 | -52.18% |
| 9 | Jpmorgan Chase & Co | $8480802 | 259352 | -6121 | -2.31% |
| 10 | Ubs Group Ag | $6776705 | 207112 | +207112 | NEW BUY |
| 11 | Bank Of New York Mellon Corp | $5375002 | 164273 | +20866 | +14.55% |
| 12 | Franklin Resources Inc | $4790044 | 146395 | +3602 | +2.52% |
| 13 | Principal Financial Group Inc | $2286474 | 69880 | +5947 | +9.30% |
| 14 | Citigroup Inc | $2268347 | 69326 | +55723 | +409.64% |
| 15 | Invesco Ltd. | $2213836 | 67660 | +67660 | NEW BUY |
| 16 | Wells Fargo & Company/Mn | $1663322 | 50835 | +30966 | +155.85% |
| 17 | Ameriprise Financial Inc | $668240 | 20423 | +20423 | NEW BUY |
| 18 | Barclays Plc | $477909 | 14606 | +4487 | +44.34% |
| 19 | Prudential Financial Inc | $294480 | 9000 | +1360 | +17.80% |
| 20 | Sei Investments Co | $288067 | 8804 | -1190 | -11.91% |
| 21 | Royal Bank Of Canada | $68000 | 2092 | +1634 | +356.77% |
| 22 | Us Bancorp \De\ | $7984 | 244 | -21 | -7.92% |
| 23 | Pnc Financial Services Group, Inc. | $1440 | 44 | — | Held |
| 24 | Amalgamated Financial Corp. | $66 | 3118 | +3118 | NEW BUY |
Aggregated across tracked institutional filers. Reported quarterly on SEC Form 13-F and may lag. For research only — not investment advice.